Long-term evaluation of anatomic and functional results after complicated retinal detachment treated with pars plana vitrectomy and heavy silicone oil tamponade.
BACKGROUND
Heavier than water tamponades offer the possibility to support the inferior part of the fundus after retinal detachment. The aim of this study was to evaluate the anatomic and functional outcome of complicated retinal detachment treated with vitreous surgery and heavy silicone oil (HSO) tamponade. Surgery was performed in eyes with rhegmatogenous retinal detachment (RD) predominantly in the lower hemisphere or with penetrating injury (either as primary intervention or after development of proliferative vitreoretinopathy [PVR]).


METHODS
Sixty-one eyes of 61 patients with RD - mostly complicated by PVR - and a minimum follow-up of 12 months were included in this study. Vitreoretinal surgery with HSO (Oxane HD) tamponade was performed in all patients. In 52 patients, heavy silicone oil was used in the management of complicated RD. 9 patients had surgery for complicated RD after penetrating eye injury.The mean follow-up period was 30.3 +/- 10.2 months.


RESULTS
The overall final anatomic success rate was 79 %. In 39 % of the cases the retina remained attached during the entire follow-up period.


CONCLUSIONS
The anatomic success rate after surgery with HSO (Oxane HD) was relatively low; however, only complex cases bearing a higher risk of retinal re-detachment received HSO in this study. Oxane HD does not appear to have major advantages compared to conventional silicone oil or other new-generation heavy silicone oils in these cases.
Regler
R
R
Augenklinik, Universitätsklinikum Regensburg. roman.regler@web.de
Sachs
H G
HG
Hillenkamp
J
J
Helbig
H
H
Framme
C
C
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009887:Ophthalmoscopy; D012163:Retinal Detachment / Q000150:complications / Q000628:therapy*; D012189:Retrospective Studies; D012827:Silicone Oils / Q000627:therapeutic use*; D013046:Specific Gravity; D016896:Treatment Outcome; D014821:Vitrectomy / Q000379:methods*; D018630:Vitreoretinopathy, Proliferative / Q000209:etiology / Q000517:prevention & control*
D012827:Silicone Oils; C539721:oxane HD